A Concept-to-Commercialization Viral Vector CDMO

Andelyn Biosciences is a gene therapy CDMO with deep expertise and experience in the development and production of viral vectors. With its origins including 20+ years of experience manufacturing viral vectors, Andelyn’s scientific expertise for development and characterization of gene therapies has led to GMP material being produced for over 75+ worldwide clinical trials and 450+ cGMP clinical batches. We support companies developing curative gene therapies for rare and prevalent diseases with plasmid manufacturing, process development, and GMP manufacturing capacity for both adherent and suspension processes up to 2,000L. An advanced digital model, quality system, full regulatory support, and supply chain vertical integration help accelerate the development and manufacturing of our clients' innovative therapies.

Play video

We support clients through all phases of development and commercialization.

Our Name

The name “Andelyn” was chosen to pay tribute to two brave young patients that participated in pivotal clinical trials that make today’s gene therapies possible.

Updates from Andelyn


November 20, 2023

Battelle, Andelyn Biosciences, and AmplifyBio Awarded Task Orders for Plasmid and Suspension AAV Vector Manufacturing and IND-enabling Studies from the National Institute of Neurological Disorders and Stroke (NINDS)

COLUMBUS, OH, Nov 20, 2023 – Battelle, Andelyn Biosciences, Inc., and AmplifyBio, have been awarded a new task order from the...


November 9, 2023

Andelyn Biosciences and The Ohio State University Collaborate for Pre-clinical and GMP Manufacturing of Novel Gene Therapies

COLUMBUS, OH, Nov 9, 2023 – Andelyn Biosciences, Inc., a pioneering and patient-focused cell and gene therapy Contract Development and...


October 20, 2023

Andelyn Biosciences and Purespring Therapeutics Partner to Manufacture Novel Gene Therapies for Kidney Diseases

COLUMBUS, OH, OCTOBER 20, 2023 – Andelyn Biosciences, Inc., a pioneering and patient-focused cell and gene therapy Contract Development and...

Play video
News & Media

June 22, 2023

Cell and Gene Therapy CDMO Andelyn Biosciences Celebrates Over 20 Years of Leadership and Innovation with Opening of New 180,000 Square Foot Manufacturing Headquarters

Columbus, Ohio – June 22, 2023 – Andelyn Biosciences, a pioneer in the development and manufacturing of cell and gene...

Our Employees Fuel Our Success

Andelyn is made up of an Inspired, Innovative and Compassionate team that contribute towards a rich company culture. We are always looking for great people who want to do great things.